Abbott's life-changing tech Lingo wins 2025 innovation award

January 17, 2025 | 11:09
(0) user say
Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to empower people to improve overall health and wellness.

The global healthcare leader was named an honoree in the Digital Health category at the 2025 CES Innovations Awards, an annual competition powered by the US Consumer Technology Association to highlight outstanding design and engineering in consumer technology products around the world.

Earlier this month, the device, manufactured with life-changing technology, was on display at the Consumer Electronics Show 2025 held from January 5-10 in Las Vegas.

Lingo was developed using the world-leading FreeStyle Libre continuous glucose monitoring technology, which is now used by more than six million people with diabetes globally. One of Abbott’s CGM systems, FreeStyle Libre 3 also stands among the company’s many CES Innovation Awards won in recent years.

“Glucose is a powerful signal of your body's unique response to food and lifestyle,” Olivier Ropars, divisional vice president of Abbott's Lingo business, said in a statement.

“Abbott's Lingo tracks your glucose 24/7, translating the data into insights and bridging the gap between traditional healthcare and preventative measures. Lingo empowers individuals to build new healthy habits and take control of their health and wellness,” he was quoted as saying.

At the show, Abbott shared that Lingo would empower consumers aged 18 and older not on insulin who are looking to improve their overall health and wellness. The system consists of a biosensor that is worn on the back of the arm for up to 14 days and continuously streams glucose data to the Lingo app on a smartphone.

Abbott's life-changing tech Lingo wins 2025 innovation award
Lingo worn by a man translates his body reaction to jogging into personal insights at the Consumer Electronics Show 2025 in Las Vegas

The system translates the body's reaction to food, exercise, and life's daily stressors into personal insights about metabolic trends to help people make informed decisions about their health.

It shows a glucose graph, and has food and activity logging, offering tailored recommendations for individuals.

Additionally, the system provides Lingo challenges, which involves creating new habits and earning badges upon the completion of challenges and the establishment of new healthy habits.

Compelling published research shows that limiting glucose spikes and improving overall management of glucose offer people who do not have diabetes a number of health benefits, such as being proactive about future health, managing weight, improving sleep, and a better mood.

Empowering people for better life

Lingo is part of Abbott’s healthcare businesses and products that also cover nutrition, medicine, diagnostics, and medical devices, which help people live more fully at all stages of life.

Abbott's life-changing tech Lingo wins 2025 innovation award
People visit Abbott’s booth at the CES 2025 where the global healthcare leader showcased its latest innovative health technology

Another Abbott product, the award-winning FreeStyle Libre, has revolutionised the way millions of people worldwide manage their diabetes.

In 2022, FreeStyle Libre was honoured as the “best of the best” since 1970 during the Prix Galien Golden Jubilee Awards. At the time, the recognition highlighted the impact of FreeStyle Libre on the lives of approximately 4.5 million people living with diabetes globally.

The FreeStyle Libre technology was brought to Vietnam in 2021. This is among the company’s diversified innovative healthcare solutions and products continuously made available in the country in Abbott’s 30 years presence in Vietnam.

In helping treat premature and newborn babies with patent ductus arteriosus (PDA), a heart defect that can develop soon after birth, the company has brought to Vietnam the Amplatzer Piccolo Occluder, a pea-sized device that helps doctors repair holes in the tiny hearts of premature and infants without riskier surgery.

Abbott has also made available in Vietnam its innovative Clinical Decision Support system, a diagnostic informatics solution that uses AI to help medical experts improve clinical management. The solution contributes to improved health screening by categorising patients based on data analysis, applying risk assessment algorithms, and providing better clinical interpretation.

Abbott and its foundation, the Abbott Fund, have provided over VND280 billion ($12 million) in grants and product donations to address critical health issues, with a focus on improving nutrition, training healthcare staff, strengthening health systems, assisting healthcare professionals on the pandemic frontline, and expanding community education.

Those efforts and solutions have contributed to advancing healthcare and empowering people throughout the nation.

PM calls on Abbott to expand investment in Vietnam PM calls on Abbott to expand investment in Vietnam

Prime Minister Pham Minh Chinh on August 9 suggested US healthcare giant Abbott expand its investment and upgrade the quality of its pharmaceutical manufacturing plants in Vietnam, thus helping promote the domestic pharmaceutical industry.

Abbott launches new Ensure Gold with innovative ingredients Abbott launches new Ensure Gold with innovative ingredients

On September 27, US healthcare giant Abbott launched the new and improved Ensure Gold in Vietnam, which features a dual action formula to support adults’ strength and immunity.

Hoan My and Abbott Vietnam partner to combat disease and brain trauma Hoan My and Abbott Vietnam partner to combat disease and brain trauma

Hoan My Medical Group and Abbott Vietnam have agreed to cooperate on improving prevention, diagnosis, and treatment of diseases and brain trauma.

By Thanh Van

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional